Cancer and pregnancy: The obstetrician's standpoint;Cancer et grossesse: Le point de vue de l'obstétricien

Bulletin du Cancer

Volumn 89, Issue 9, 2002, Pages 758-764

  Mathieu, Emmanuelle ^a   Merviel, Philippe ^a   Antoine, Jean Marie ^a   Uzan, Serge ^a  

^a HÔPITAL TENON   (France)

Author keywords

Cancer; Chemotherapy; Fetus; Pregnancy; Radiotherapy

Indexed keywords

BIRTH DEFECT; BRAIN TUMOR; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER THERAPY; CONSERVATIVE TREATMENT; FEMALE; FEMALE FERTILITY; FETUS WASTAGE; HUMAN; LEUKEMIA; LYMPHOMA; MELANOMA; OVARY CANCER; PREGNANCY; PREMATURE LABOR; PROGNOSIS; REVIEW; SPONTANEOUS ABORTION; TREATMENT PLANNING; UTERINE CERVIX CANCER; ARTICLE; BREAST TUMOR; DECISION MAKING; FERTILITY; INDUCED ABORTION; OBSTETRICS; ONCOLOGY; OVARY TUMOR; PREGNANCY COMPLICATION; PSYCHOLOGICAL ASPECT; RADIOGRAPHY; RADIOTHERAPY; SECOND CANCER; UTERINE CERVIX CONIZATION;

ANTINEOPLASTIC AGENT;

ABORTION, INDUCED; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CONIZATION; DECISION MAKING; FEMALE; FERTILITY; HUMANS; MEDICAL ONCOLOGY; NEOPLASMS, SECOND PRIMARY; OBSTETRICS; OVARIAN NEOPLASMS; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PROGNOSIS; RADIOTHERAPY;

EID: 0036708513     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Waalen J. Pregnancy poses tough questions for cancer treatment. J Natl Cancer Inst 1991; 83: 900.
2. Haas JF. Pregnancy in association with a newly diagnosed cancer: a population-based epidemiologic assessment. Int J Cancer 1984; 34: 229-35.
3. Publication 84 de la Commission internationale de protection radiologique. Grossesse et irradiation médicale. Éd. EDP Sciences, 2001.
4. Sharp C, Shrimpton JA, Bury RF. Diagnostic medical exposures: advice on exposure to ionising radiation during pregnancy. National Radiological Protection Board, Chilton, Didcot, Oxon, UK, 1998.
5. Doll R, Wakeford R. Risk of chidhood cancer from fetal irradiation. Br J Radiol 1997; 70: 130-9.
6. American Association of Physicists in Medecine. Stovall, Blackwell, Cundiff et coll. 1995.
7. Buekers T, Lallas T. Chemotherapy in pregnancy. Obstet Gynecol Clin North Am 1998; 25: 323-9.
8. Ebert U, Loffler H, Kirch W. Cytotoxic therapy and pregnancy. Pharmacol Ther 1997; 74: 207-20.
9. Redmond GP. Physiological changes during pregnancy and their implications for pharmacological treatment. Clin Invest Med 1985; 8: 317-22.
10. Zemlickis D, Lishner M, Degendorfer P, Panzarella T, Sutcliffe SB, Koren G, et al. Fetal outcome after in utero exposure to cancer chemotherapy. Arch Intern Med 1992; 152: 573-6.
11. Garcia L, Valcarcel M, Santiago-Borrero P. Chemotherapy during pregnancy and its effects on the fetus-neonatal myelosuppression: two case reports. J Perinatol 1999; 19: 230-3.
12. Cygler J, Ding G, Kendal W, Cross P. Fetal dose for a patient undergoing mantle field irradiation for Hodgkin's disease. Med Dosimetry 1997; 22: 135-7.
13. Wiebe V, Sipila P. Pharmacology of antineoplastic agents in pregnancy. Crit Rev Oncol Hematol 1994; 16: 75-112.
14. Sorosky F, Sood A, Buekers T. The use of chemotherapeutic agents during pregnancy. Obstet Gynecol Clin North Am 1997; 24: 591-9.
15. Wagner V, Hill J, Weaver D, Baehner R. Congenital abnormalities in baby born to cytarabine treated mother. Lancet 1980: 98-9.
16. Turchi J, Villasis C. Anthracyclines in the treatment of malignancy in pregnancy. Cancer 1988; 61: 435-40.
17. Achtari C, Hohlfeld P. Cardiotoxic transplacental effect of idarubicin administered during the second trimester of pregnancy. Am J Obstet Gynecol 2000; 183: 511-2.
18. Reynoso E, Huerta F. Acute leukemia and pregnancy: fatal fetal outcome after exposure to idarubicin during the second trimester. Acta Oncol 1994; 33: 703-16.
19. Schaison G, Jacquillat C, Auclerc G, Weill M. Les risques fœtoembryonnaires des chimiotherapies. Bull Cancer 1979; 66: 165-70.
20. Claahsen H, Semmekrot B, Van Dongen P, Mattijsen V. Successful fetal outcome after exposure to idarubicin and cytosine-arabinoside during the second trimester of pregnancy-a case report. Am J Perinatol 1998; 15: 295-7.
21. Ramsey-Goldman R. The risk of cytotoxic drugs during pregnancy. Scand J Rheumatol 1998; 27: 133-5.
22. Thomas PR, Peckam MJ. The investigation and management of Hodgkin's disease in the pregnant patient. Cancer 1976; 38: 1443-51.
23. Blanford AT, Murphy BP. In vitro metabolism of prednisolone, dexamethasone, betamethasone, and cortisol by the human placenta. Am J Obstet Gynecol 1977; 27: 264-7.
24. Bahtia S, Robison LL, Oberlin O, Greenberg M, Bunin G. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 1996; 334: 745-51.
25. Sankila R, Heinävaara S, Hakulinen T. Survival of breast cancer patients after subsequent term pregnancy: healthy more effect. Am J Obstet Gynecol 1994; 170: 818-23.
26. Lutz MH, Underwood PB, Rozier JC, Putney FW. Genital malignancy in pregnancy. Am J Obstet Gynecol 1977; 129: 536-42.
27. Li F, Gimbrere K, Gelber R, Sallan SE, Flamant F, Green DM. Outcome of pregnancy in survivor of Wilm's tumor. JAMA 1987; 257: 216-9.
28. Michel G, Castaigne D, Lhommé C. Place du traitement conservateur dans les tumeurs ovariennes malignes et à la limite de la malignité. Reprod Hum Horm 1995; 8: 461-6.
29. Holzer E, Picked H. The extent of the atypical squamous epithelium of the cervix uteri. Arch Geschwulstforsch 1975; 45: 79-91.
30. Leiman G, Harrison NA, Rubin A. Pregnancy following conization of the cervix: complications related to cone size. Am J Obstet Gynecol 1980; 136: 14-8.
31. Sutton R, Busdar AU, Hortobagyi GN. Pregnancy and offspring after adjuvant chemotherapy in breast cancer patients. Cancer 1990; 65: 847-50.
32. Mignot L, Morvan F, Berdah J, Querleu D, Laurent JC, Verhaeghe M, et al. Grossesses après cancer du sein traité. Résultats d'une étude castémoins. Presse Med 1986; 15: 1961-4.